Reconstruction of the soft tissue of a deep diabetic foot wound with artificial dermis and recombinant basic fibroblast growth factor

Plastic and Reconstructive Surgery

Volumn 115, Issue 2, 2005, Pages 567-572

  Ito, Kazuo ^a,b,c   Ito, Shigemi ^a,b   Sekine, Masatoshi ^a,b   Abe, Masataka ^a,b  

^a Takikawa Municipal Hospital ^*

^b KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE GLUCONATE; FUSIDATE SODIUM; HEMOGLOBIN A1C; INSULIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL SKIN; CASE REPORT; DEBRIDEMENT; DIABETIC FOOT; DIABETIC RETINOPATHY; DISINFECTION; EPITHELIZATION; FOOT ULCER; FREE SKIN GRAFT; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOFT TISSUE DEFECT; WOUND CLOSURE; WOUND INFECTION;

ADMINISTRATION, TOPICAL; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FIBROBLAST GROWTH FACTOR 2; HALLUX; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SKIN, ARTIFICIAL;

EID: 14044253612     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000149485.60638.30     Document Type: Article

References (16)

1. Caputo, G. M., Cavanagh, P. R., Ulbrecht, J. S., Gibbons, G. W., and Karchmer, A. W. Assessment and management of foot disease in patients with diabetes. N. Engl. J. Med. 331: 854, 1994.
2. American Diabetes Association. Consensus development conference on diabetic foot wound care. Diabetes Care 22: 1354, 1999.
3. Lai, C. S., Lin, S. D., Yang, C. C., Chou, C. K., Wu, S. F., and Chang, C. H. Limb salvage of infected diabetic foot ulcers with microsurgical free-muscle transfer. Ann. Plast. Surg. 26: 212, 1991.
4. Gentzkow, G. D., Prendergast, J. J., Iwasaki, S. D., et al. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 19: 350, 1996.
5. Veves, A., Falanga, V., Armstrong, D. G., and Sabolinski, M. L. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers. Diabetes Care 24: 290, 2001.
6. Suzuki, S., Matsuda, K., Isshiki, N., Tamada, Y., Yoshioka, K., and Ikada, Y. Clinical evaluation of a new bilayer "artificial skin" composed of collagen sponge and silicone layer. Br. J. Plast. Surg. 43: 47, 1990.
7. Yannas, I. V., and Burke, J. F. Design of an artificial skin: I. Basic design principles. J. Biomed. Mater. Res. 14: 65, 1980.
8. Okumura, M., Okuda, T., Nakamura, T., and Yajima, M. Effect of basic fibroblast growth factor on wound healing in healing-impaired animal models. Arzneimittelforschung 46: 547, 1996 (erratum in Arzneimittelforschung 47: 222, 1997).
9. Okumura, M., Okuda, T., Nakamura, T., and Yajima, M. Effect of basic fibroblast growth factor on wound healing in healing-impaired animal models. Arzneimittelforschung 46: 547, 1996 (erratum in Arzneimittelforschung 47: 222, 1997).
10. Ono, I., Tateshita, T., and Inoue, M. Effects of a collagen matrix containing basic fibroblast growth factor on wound contraction. J. Biomed. Mater. Res. 48: 621, 1999.
11. Lavery, L. A., Armstrong, D. G., and Harkless, L. B. Classification of diabetic foot wounds. Foot Ankle Int. 35: 528, 1996.
12. Suzuki, S., Matsuda, K., Maruguchi, T., Nishimura, Y., and Ikada, Y. Further applications of "bilayer artificial skin." Br. J. Plast. Surg. 48: 222, 1995.
13. Gospodarowicz, D. Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249: 123, 1974.
14. Hayward, P., Hokanson, J., Heggers, J., et al. Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am. J. Surg. 163: 288, 1992.
15. Steed, D. L., Edington, H. D., and Webster, M. W. Recurrence rate of diabetic neurotrophic foot ulcers healed using topical application of growth factors released from platelets. Wound Repair Regen. 4: 230, 1996.
16. Kawai, K., Suzuki, S., Tabata, Y., Ikada, Y., and Nishimura, Y. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 21: 489, 2000.